Cargando…

Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment

INTRODUCTION: Heterogeneity in risk of conversion to Alzheimer's disease (AD) among individuals with mild cognitive impairment (MCI) is well known. Novel statistical methods that are based on partially ordered set (poset) models can be used to create models that provide detailed and accurate in...

Descripción completa

Detalles Bibliográficos
Autores principales: Tatsuoka, Curtis, Tseng, Huiyun, Jaeger, Judith, Varadi, Ferenc, Smith, Mark A, Yamada, Tomoko, Smyth, Kathleen A, Lerner, Alan J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707057/
https://www.ncbi.nlm.nih.gov/pubmed/23497709
http://dx.doi.org/10.1186/alzrt168
_version_ 1782276462355677184
author Tatsuoka, Curtis
Tseng, Huiyun
Jaeger, Judith
Varadi, Ferenc
Smith, Mark A
Yamada, Tomoko
Smyth, Kathleen A
Lerner, Alan J
author_facet Tatsuoka, Curtis
Tseng, Huiyun
Jaeger, Judith
Varadi, Ferenc
Smith, Mark A
Yamada, Tomoko
Smyth, Kathleen A
Lerner, Alan J
author_sort Tatsuoka, Curtis
collection PubMed
description INTRODUCTION: Heterogeneity in risk of conversion to Alzheimer's disease (AD) among individuals with mild cognitive impairment (MCI) is well known. Novel statistical methods that are based on partially ordered set (poset) models can be used to create models that provide detailed and accurate information about performance with specific cognitive functions. This approach allows for the study of direct links between specific cognitive functions and risk of conversion to AD from MCI. It also allows for further delineation of multi-domain amnestic MCI, in relation to specific non-amnestic cognitive deficits, and the modeling of a range of episodic memory functioning levels. METHODS: From the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, conversion at 24 months of 268 MCI subjects was analyzed. It was found that 101 of those subjects (37.7%) converted to AD within that time frame. Poset models were then used to classify cognitive performance for MCI subjects. Respective observed conversion rates to AD were calculated for various cognitive subgroups, and by APOE e4 allele status. These rates were then compared across subgroups. RESULTS: The observed conversion rate for MCI subjects with a relatively lower functioning with a high level of episodic memory at baseline was 61.2%. In MCI subjects who additionally also had relatively lower perceptual motor speed functioning and at least one APOE e4 allele, the conversion rate was 84.2%. In contrast, the observed conversion rate was 9.8% for MCI subjects with a relatively higher episodic memory functioning level and no APOE e4 allele. Relatively lower functioning with cognitive flexibility and perceptual motor speed by itself also appears to be associated with higher conversion rates. CONCLUSIONS: Among MCI subjects, specific baseline cognitive profiles that were derived through poset modeling methods, are clearly associated with differential rates of conversion to AD. More precise delineation of MCI by such cognitive functioning profiles, including notions such as multidomain amnestic MCI, can help in gaining further insight into how heterogeneity arises in outcomes. Poset-based modeling methods may be useful for providing more precise classification of cognitive subgroups among MCI for imaging and genetics studies, and for developing more efficient and focused cognitive test batteries.
format Online
Article
Text
id pubmed-3707057
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-37070572013-07-10 Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment Tatsuoka, Curtis Tseng, Huiyun Jaeger, Judith Varadi, Ferenc Smith, Mark A Yamada, Tomoko Smyth, Kathleen A Lerner, Alan J Alzheimers Res Ther Research INTRODUCTION: Heterogeneity in risk of conversion to Alzheimer's disease (AD) among individuals with mild cognitive impairment (MCI) is well known. Novel statistical methods that are based on partially ordered set (poset) models can be used to create models that provide detailed and accurate information about performance with specific cognitive functions. This approach allows for the study of direct links between specific cognitive functions and risk of conversion to AD from MCI. It also allows for further delineation of multi-domain amnestic MCI, in relation to specific non-amnestic cognitive deficits, and the modeling of a range of episodic memory functioning levels. METHODS: From the Alzheimer's Disease Neuroimaging Initiative (ADNI) study, conversion at 24 months of 268 MCI subjects was analyzed. It was found that 101 of those subjects (37.7%) converted to AD within that time frame. Poset models were then used to classify cognitive performance for MCI subjects. Respective observed conversion rates to AD were calculated for various cognitive subgroups, and by APOE e4 allele status. These rates were then compared across subgroups. RESULTS: The observed conversion rate for MCI subjects with a relatively lower functioning with a high level of episodic memory at baseline was 61.2%. In MCI subjects who additionally also had relatively lower perceptual motor speed functioning and at least one APOE e4 allele, the conversion rate was 84.2%. In contrast, the observed conversion rate was 9.8% for MCI subjects with a relatively higher episodic memory functioning level and no APOE e4 allele. Relatively lower functioning with cognitive flexibility and perceptual motor speed by itself also appears to be associated with higher conversion rates. CONCLUSIONS: Among MCI subjects, specific baseline cognitive profiles that were derived through poset modeling methods, are clearly associated with differential rates of conversion to AD. More precise delineation of MCI by such cognitive functioning profiles, including notions such as multidomain amnestic MCI, can help in gaining further insight into how heterogeneity arises in outcomes. Poset-based modeling methods may be useful for providing more precise classification of cognitive subgroups among MCI for imaging and genetics studies, and for developing more efficient and focused cognitive test batteries. BioMed Central 2013-03-06 /pmc/articles/PMC3707057/ /pubmed/23497709 http://dx.doi.org/10.1186/alzrt168 Text en Copyright © 2013 Tatsuoka et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Tatsuoka, Curtis
Tseng, Huiyun
Jaeger, Judith
Varadi, Ferenc
Smith, Mark A
Yamada, Tomoko
Smyth, Kathleen A
Lerner, Alan J
Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title_full Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title_fullStr Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title_full_unstemmed Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title_short Modeling the heterogeneity in risk of progression to Alzheimer's disease across cognitive profiles in mild cognitive impairment
title_sort modeling the heterogeneity in risk of progression to alzheimer's disease across cognitive profiles in mild cognitive impairment
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707057/
https://www.ncbi.nlm.nih.gov/pubmed/23497709
http://dx.doi.org/10.1186/alzrt168
work_keys_str_mv AT tatsuokacurtis modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT tsenghuiyun modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT jaegerjudith modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT varadiferenc modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT smithmarka modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT yamadatomoko modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT smythkathleena modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT lerneralanj modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment
AT modelingtheheterogeneityinriskofprogressiontoalzheimersdiseaseacrosscognitiveprofilesinmildcognitiveimpairment